GGrantIndex
← Leaderboards

Philip C Trackman

Boston University Medical Campus

$8,243,262
Attributed
$8,748,881
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $721.8K · FY200524
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$8,748,881 · 10

By mechanism

R01$6,776,273 · 3
R21$1,328,756 · 3
R56$612,048 · 1
M01$31,804 · 3

Top collaborators

Most similar at Boston University Medical Campus

Same institution · by research overlap

Others in their field

Top investigators on “Collagen

Research focus

CollagenExtracellular MatrixGrowth FactorCellsExtracellularIn VivoMediatingGene ExpressionIn VitroRegulationEnzymesDown-RegulationGenesOsteoblastsSignal TransductionCrosslinkPathway InteractionsProductionConnective TissueAffectLeadApoptosisFibrosisTissues

Grant awards (34)

Mechanism of lysyl oxidase propeptide in oral squamous cell carcinoma microenvironments$612,048
R56 · FY2024 · DE · contact PI
Osteoblast Dopamine Receptor Mediates Diabetic Bone Disease$216,711
R21 · FY2022 · AR · contact PI
Osteoblast Dopamine Receptor Mediates Diabetic Bone Disease$262,680
R21 · FY2021 · AR · contact PI
Mechanism of Bone Marrow Neoplasm-Induced Osteosclerosis$181,500
R21 · FY2019 · AR · contact PI
Mechanism of Bone Marrow Neoplasm-Induced Osteosclerosis$217,690
R21 · FY2018 · AR · contact PI
Cellular or Extracellular Targeting of Lysyl Oxidase Propeptide for Oral Cancer$204,625
R21 · FY2015 · DE · contact PI
Cellular or Extracellular Targeting of Lysyl Oxidase Propeptide for Oral Cancer$245,550
R21 · FY2014 · DE · contact PI
Inhibited Intramembranous Bone Healing in Diabetes$326,814
R01 · FY2013 · DE · contact PI
Inhibited Intramembranous Bone Healing in Diabetes$340,431
R01 · FY2012 · DE · contact PI
Growth Factors and Gingival Fibrosis$336,830
R01 · FY2011 · DE · contact PI
Inhibited Intramembranous Bone Healing in Diabetes$333,554
R01 · FY2011 · DE · contact PI
Growth Factors and Gingival Fibrosis$347,248
R01 · FY2010 · DE · contact PI
Inhibited Intramembranous Bone Healing in Diabetes$343,870
R01 · FY2010 · DE · contact PI
Inhibited Intramembranous Bone Healing in Diabetes$371,094
R01 · FY2009 · DE · contact PI
Growth Factors and Gingival Fibrosis$350,755
R01 · FY2009 · DE · contact PI
Growth Factors and Gingival Fibrosis$350,755
R01 · FY2008 · DE · contact PI
Growth Factors and Gingival Fibrosis$363,750
R01 · FY2007 · DE · contact PI
INHIBITED INTRAMEMBRANEOUS BONE HEALING IN DIABETES$254,581
R01 · FY2007 · DE · contact PI
GROWTH FACTORS AND GINGIVAL FIBROSIS$13,890
M01 · FY2007 · RR · contact PI
INHIBITED INTRAMEMBRANEOUS BONE HEALING IN DIABETES$262,184
R01 · FY2006 · DE · contact PI
GROWTH FACTORS AND GINGIVAL FIBROSIS$262,184
R01 · FY2006 · DE · contact PI
GROWTH FACTORS AND GINGIVAL FIBROSIS$2,316
M01 · FY2006 · RR · contact PI
INHIBITED INTRAMEMBRANEOUS BONE HEALING IN DIABETES$268,494
R01 · FY2005 · DE
GROWTH FACTORS AND GINGIVAL FIBROSIS$268,494
R01 · FY2005 · DE
GROWTH FACTORS AND GINGIVAL FIBROSIS$2,578
M01 · FY2005 · RR
GROWTH FACTORS AND GINGIVAL FIBROSIS$268,494
R01 · FY2004 · DE
INHIBITED INTRAMEMBRANEOUS BONE HEALING IN DIABETES$268,494
R01 · FY2004 · DE
Growth Factors and Gingival Fibrosis$13,020
M01 · FY2004 · RR
INHIBITED INTRAMEMBRANEOUS BONE HEALING IN DIABETES$268,494
R01 · FY2003 · DE
GROWTH FACTORS AND GINGIVAL FIBROSIS$268,494
R01 · FY2003 · DE
GROWTH FACTORS AND GINGIVAL FIBROSIS$295,165
R01 · FY2002 · DE
MECHANISMS OF MINERALIZED MATRIX ACCUMULATION$215,930
R01 · FY2002 · DE
MECHANISMS OF MINERALIZED MATRIX ACCUMULATION$209,639
R01 · FY2001 · DE
MECHANISMS OF MINERALIZED MATRIX ACCUMULATION$200,525
R01 · FY2000 · DE